Wide lips may need strategic volume rather than overall fullness
Wegovy, also known as semaglutide, will now be available to thousands of obese individuals in England through the NHS
Annessi G, Cattaruzza MS, Abeni D, Baliva G, Laurenza M, Macchini V et al
The drug is classified as a Schedule IV controlled substance due to its stimulant properties and potential for psychological dependence over time
This is why it is important to understand what additional weight management efforts patients pursue in real-world settings after discontinuing semaglutide or tirzepatide, and whether long-term weight changes after discontinuation follow the patterns reported in randomized clinical trials. Hamlet Gasoyan, DS, PhD, MPH According to the researchers, a potential reason for the difference may be that people often continue their treatment journey in other ways